Comparison of predicting scales for symptomatic intracranial hemorrhage after stroke thrombolysis with recombinant tissue plasminogen activator

被引：0
|
作者：
朱珏华 [1 ]
机构：
[1] Dept Neurol,1st Hosp,Suzhou Univ
来源：
China Medical Abstracts (Internal Medicine) | 2020年 / 37卷 / 01期
关键词：
Comparison of predicting scales for symptomatic intracranial hemorrhage after stroke thrombolysis with recombinant tissue plasminogen activator;
D O I：
暂无
中图分类号：
R743.3 [急性脑血管疾病（中风）];
学科分类号：
1002 ;
摘要：
Objective Symptomatic intracranial hemorrhage(sICH) is one of the severe complications of ischemic stroke thrombolysis.Several prognostic scales have been developed to predict the risk of sICH.The performance of seven scales was compared in a single center cohort.Methods Data of patients with consecutive ischemic stroke who received 0.9 mg/kg intravenous recombinant tissue plasminogen activator (rt-PA) thrombolysis within
引用
收藏
页码：62 / 63
页数：2
相关论文
共 50 条
  • [31] Treatment of Intracerebral Hemorrhage with Tranexamic Acid After Thrombolysis with Tissue Plasminogen Activator
    K. F. French
    Jacob White
    R. E. Hoesch
    [J]. Neurocritical Care, 2012, 17 : 107 - 111
  • [32] Thrombolysis for acute ischemic stroke with recombinant tissue plasminogen activator in a Chilean public hospital
    Figueroa-Reyes, Tatiana
    Saez M, David
    Mansilla L, Eloy
    Sanchez, Rodrigo, V
    Nogales-Gaete, Jorge
    Delgado B, Iris
    [J]. REVISTA MEDICA DE CHILE, 2011, 139 (09) : 1118 - 1127
  • [33] Risk Factors for Symptomatic Intracranial Hemorrhage After Intravenous Thrombolysis for Acute Stroke
    Wong, Crystal T.
    Spataru, Oana
    Lepere, Darren
    Jovin, Tudor G.
    Zaidi, Syed F.
    Massaro, Lori
    Hammer, Maxim D.
    Reddy, Vivek
    Wechsler, Lawrence R.
    Jumaa, Mouhammad A.
    [J]. STROKE, 2011, 42 (03) : E138 - E138
  • [34] Predictors of In-hospital Mortality and the Risk of Symptomatic Intracerebral Hemorrhage after Thrombolytic Therapy with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
    Al-Khaled, Mohamed
    Matthis, Christine
    Eggers, Juergen
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (01): : 7 - 11
  • [35] Stroke thrombolysis: Is tissue plasminogen activator a defibrillator for the brain?
    Buchan, AM
    Feasby, TE
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2000, 162 (01) : 47 - 48
  • [36] Thrombolysis (tissue plasminogen activator) in stroke - A medicolegal quagmire
    Weintraub, Michael I.
    [J]. STROKE, 2006, 37 (07) : 1917 - 1922
  • [37] Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage - Comments
    Connolly, ES
    Amar, AP
    Lawton, MT
    [J]. NEUROSURGERY, 2004, 55 (03) : 537 - 538
  • [38] Characteristics of blood tests in patients with acute cerebral infarction who developed symptomatic intracranial hemorrhage after intravenous administration of recombinant tissue plasminogen activator
    Lee, Chungjo
    Na, Ji Ung
    Lee, Jang Hee
    Han, Sang Kuk
    Choi, Pil Cho
    Lee, Young Hwan
    Park, Sang O.
    Shin, Dong Hyuk
    [J]. CLINICAL AND EXPERIMENTAL EMERGENCY MEDICINE, 2019, 6 (02): : 160 - 168
  • [39] HEMORRHAGE-FREE THROMBOLYSIS BY TISSUE PLASMINOGEN-ACTIVATOR IN RABBITS - A COMPARISON WITH STREPTOKINASE
    BUCHANAN, MR
    BONEU, B
    AGNELLI, G
    HIRSH, J
    COLLEN, D
    [J]. CLINICAL RESEARCH, 1984, 32 (02): : A494 - A494
  • [40] A Four-Year Experience of Symptomatic Intracranial Hemorrhage Rate Following Intravenous Tissue Plasminogen Activator at a Comprehensive Stroke Center
    Wagner, Jeffrey C.
    Orlando, Alessandro
    Fanale, Christopher V.
    Whaley, Michelle
    McCarthy, Kathryn L.
    Bar-Or, David
    [J]. STROKE, 2015, 46
12345